Key Takeaways
- President Trump announced immediate $90 rebates for over 20 million seniors to cover Medicare Part B premiums, while renewing a campaign promise for a $5,000 "Trump Dividend" for all U.S. citizens if Republicans win the 2026 midterms.
- GameStop (GME) CEO Ryan Cohen purchased 700,000 shares of the company for approximately $17.1 million, signaling strong insider confidence despite the stock trading significantly above its estimated intrinsic value.
- Qualcomm (QCOM) filed a prospectus for the potential resale of up to 25 million common shares by existing stockholders; the company will not receive proceeds from these secondary sales.
- Novo Nordisk (NVO) faces a delay in the FDA review of its hemophilia A treatment, denecimig, due to ongoing manufacturing facility remediation, though clinical data remains unchallenged.
- A U.S. appeals court temporarily blocked Minnesota’s first-in-the-nation ban on AI "nudification" technology following a legal challenge from Elon Musk’s xAI.
Trump Targets Senior Costs and Midterm Incentives
President Donald Trump has initiated a series of financial maneuvers aimed at senior citizens and the broader electorate just weeks before the 2026 midterm elections. The administration announced that more than 20 million seniors will receive one-time payments of $90 (nearly $100) to assist with Medicare Part B premiums. These funds are being drawn from the Medicare Improvement Fund, a $2 billion reserve that the President characterized as a "slush fund" previously underutilized by past administrations.
In addition to the immediate rebates, Trump doubled down on his proposal for a $5,000 "Trump Dividend" for every adult U.S. citizen. The President stated that this payout—estimated to cost roughly $1.2 trillion—would be contingent on Republicans retaining control of both the House and Senate. While Trump suggested tariff revenue could fund the program, economists have noted that current tariff receipts cover only a fraction of the proposed cost, and the plan would require significant Congressional approval.
Corporate Developments: GameStop and Qualcomm
GameStop (GME) CEO Ryan Cohen made a substantial market move on Friday, acquiring 700,000 shares at an average price of $24.41 per share. The $17.1 million investment increases Cohen's direct ownership to over 41.6 million shares. While the purchase sparked a modest gain in after-hours trading, analysts at GuruFocus noted that the stock remains approximately 64% overvalued relative to its intrinsic value of $15.03.
Meanwhile, Qualcomm (QCOM) has cleared the way for a major secondary offering. The semiconductor giant filed a prospectus with the SEC for the resale of up to 25 million shares by certain stockholders. As a secondary offering, Qualcomm itself will not receive any capital from the transactions, which typically involve large institutional holders or early investors seeking liquidity.
Regulatory and Geopolitical Updates
The FDA has extended its review of Novo Nordisk’s (NVO) Biologics License Application (BLA) for denecimig, a treatment for haemophilia A. The delay is attributed to facility remediation at a manufacturing site rather than concerns over clinical efficacy or safety. Novo Nordisk maintains its goal of a U.S. launch in the first half of 2027, stating the delay does not impact its 2026 financial outlook.
In the technology sector, Elon Musk’s xAI successfully petitioned a federal appeals court to halt Minnesota’s ban on AI-generated "nudification" images. The court's stay allows the company to pursue its lawsuit alleging the law infringes on constitutional protections, despite fierce opposition from state legislators who argue the technology facilitates the exploitation of women and children.
On the geopolitical front, Axios reported a secret meeting of top national security aides at Camp David. Chaired by Vice President JD Vance, the session focused on escalating tensions in the Iran war and the ongoing conflict in Yemen. The meeting comes amid heightened regional instability and follows recent U.S. military strikes in the region.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.